A candidate drug, which acts in a novel way, has shown promising results in the laboratory against advanced prostate cancer that was insensitive to reduced levels of male sex hormones, according to

Cuban scientists said they have concluded the second round of the clinical trial of a potential vaccine against prostate cancer.

The Food and Drug Administration approved the first treatment that uses a so-called cancer vaccine, a drug that trains the body